Madec
Alain Madec, Villebon S/yvette FR
Patent application number | Description | Published |
---|---|---|
20130330936 | METHOD OF DEPOSITION OF Al2O3/SiO2 STACKS, FROM ALUMINIUM AND SILICON PRECURSORS - A method of forming an Al | 12-12-2013 |
Alain Paul Madec, Chartrettes FR
Patent application number | Description | Published |
---|---|---|
20110110781 | DEVICE FOR FASTENING A VARIABLE PITCH BLADE - This blade attachment device comprises a shell ( | 05-12-2011 |
20130108434 | METHOD FOR MOUNTING A STATOR BLADING OF A TURBOMACHINE, AN ENGINE CASING AND A TURBOMACHINE COMPRISING AT LEAST ONE STATOR BLADING MOUNTED ON THIS ENGINE CASING | 05-02-2013 |
Frederic Madec, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20110158973 | SUPPRESSION OF CANCERS - The present invention relates to a method for suppressing or treating cancer, in particular to a method for suppressing or treating one or more of colorectal cancer, breast cancer, prostate cancer and/or lung cancer. The therapy employs use of a non-cytotoxic protease, which is targeted to a growth hormone-secreting cell such as to a pituitary cell. When so delivered, the protease is internalised and inhibits secretion/transmission of growth hormone from said cell. The present invention also relates to polypeptides and nucleic acids for use in said methods. | 06-30-2011 |
20140219983 | SUPPRESSION OF CANCERS - The present invention relates to a method for suppressing or treating cancer, in particular to a method for suppressing or treating one or more of colorectal cancer, breast cancer, prostate cancer and/or lung cancer. The therapy employs use of a non-cytotoxic protease, which is targeted to a growth hormone-secreting cell such as to a pituitary cell. When so delivered, the protease is internalised and inhibits secretion/transmission of growth hormone from said cell. The present invention also relates to polypeptides and nucleic acids for use in said methods. | 08-07-2014 |
20140286925 | SUPPRESSION OF CANCER - The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell. | 09-25-2014 |
Frederic Madec, Oxon GB
Patent application number | Description | Published |
---|---|---|
20110165137 | SUPPRESSION OF CANCERS - The present invention relates to a method for suppressing or treating cancer, in particular to a method for suppressing or treating one or more of colorectal cancer, breast cancer, prostate cancer and/or lung cancer. The therapy employs use of a non-cytotoxic protease, which is targeted to a growth hormone-secreting cell such as to a pituitary cell. When so delivered, the protease is internalised and inhibits secretion/transmission of growth hormone from said cell. The present invention also relates to polypeptides and nucleic acids for use in said methods. | 07-07-2011 |
Frederic Madec, Oxfordshire GB
Patent application number | Description | Published |
---|---|---|
20110262423 | SUPPRESSION OF CANCER - The present invention relates to polypeptides for use in suppressing cancer and cancer disorders. The treatment employs use of a non-cytotoxic protease, which is targeted to the cancer cell, and, when so delivered, the protease is internalised and inhibits secretion from the cancer cell. | 10-27-2011 |
Jonathan Madec, Chatou FR
Patent application number | Description | Published |
---|---|---|
20130231500 | METHOD FOR THE PREPARATION OF (3S, 3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) - The present invention relates to a new method for the preparation of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) in five steps from (S)-ethyl 2-(benzyloxycarbonylamino)-4-(neopentyloxysulfonyl)butanoate A. | 09-05-2013 |
20140221668 | Process - The present invention relates to a process for preparing (R)-5-(2-(benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione, and pharmaceutically acceptable salts thereof, especially the hydrochloride salt. The invention also relates to a process for making intermediates useful in the formation of said compound, and to the intermediates, per se. | 08-07-2014 |
20150246869 | Process for Preparing Cinacalcet and Pharmaceutically Acceptable Salts Thereof - The present patent application relates to a process for preparing, cinacalcet or a pharmaceutically acceptable salt thereof, which comprises reacting 3-trifluoromethylbenzaldehyde having the following formula (II) with the phosphorus-comprising derivative having the following formula all) in which R | 09-03-2015 |
Lenaic Madec, Gueret FR
Patent application number | Description | Published |
---|---|---|
20140302386 | COMPOUNDS HAVING A REDOX GROUP, USE THEREOF AS AN ELECTROLYTE ADDITIVE, ELECTROLYTE COMPOSITION, AND ELECTROCHEMICAL SYSTEMS CONTAINING SAME - The invention relates to compounds comprising a redox group, to the use thereof as an additive to an electrolyte composition, to an electrolyte composition including such an additive, and to electrochemical systems including such an electrolyte composition, in particular lithium or sodium batteries and supercapacitors having a double electric layer. | 10-09-2014 |
Yoann Madec, Paris FR
Patent application number | Description | Published |
---|---|---|
20150247853 | LEVELS OF CXCL 10/IP-10 FORMS AND SOLUBLE CD26/DPPIV ACTIVITY AS EARLY PREDICTIVE BIOMARKERS FOR HIV/SIV ASSOCIATED MUCOSAL INFLAMMATION AND PROGRESSION TOWARDS AIDS - The invention provides methods for the identification of patients capable of controlling HIV progression, as well as to the identification of an antagonist form of IP-10 associated to HIV progression control and the uses thereof for improving the immunological response of HIV patients. | 09-03-2015 |
Yves Madec, Vendome FR
Patent application number | Description | Published |
---|---|---|
20150275521 | WATER PROOFING MEMBRANE, AND A METHOD FOR MAKING A WATER PROOFING MEMBRANE - The invention relates to a waterproofing membrane ( | 10-01-2015 |